W
QUALITY CONTROL
Human ready-to-use stable liquid multi-analyte control for specific
proteins including antibody isotypes and complement components
Spon-Smith C., Shanks A., Rodríguez M.L., Campbell J., FitzGerald S.P | Randox Laboratories Ltd - Diamond Road, Crumlin, County Antrim, N. Ireland, BT29 4QY, United Kingdom.
Introduction
The performance and interpretation of tests for the diagnosis and management of a variety
of immune-mediated diseases requires the maintenance of high-quality output. Quality
control material is required to monitor the accuracy and precision of the tests,this will lead
to improved result quality.
The use of liquid stable multi-analyte control material consolidates the test menu, reduces
the risk of errors associated with reconstitution and decreases the operator training
requirements. A human liquid ready-to-use,stable multi-analyte control containing antibody
isotypes, complement components and other specific proteins is reported.
Methodology
•Three levels of human liquid control material containing 27 analytes were prepared.
• Open vial stability was determined as the percentage recovery of each level of analyte
opened and stored at +2°C to +8°C over a period of 30 days related to day 0 at
+2°C to +8°C.
• Shelf life was assessed as the percentage recovery of each level of analyte stored at
+2°C to +8°C compared to the same material stored at -70°C over a 48 month period.
Measurements were made on various automated systems.
Conclusion
Thehumanliquidmulti-analytecontrolmaterialforspecificproteinscontained27parameters
at three levels covering clinically relevant ranges.This control material presented an open
vial stability of 30 days and data supporting at least a 2 year shelf life.This control is of value
as a convenient, ready-to-use material for clinical applications.
Randox Laboratories Ltd, 55 Diamond Road, Crumlin, County Antrim, BT29 4QY, United Kingdom
+44 (0) 28 9442 2413 +44 (0) 28 9445 2912 marketing@randox.com randoxqc.comQUALITY CONTROL
Analyte Unit
Level 1 Level 2 Level 3
Method
Target Range Target Range Target Range
CRP
mg/L 27.5 22.0-33.0 54.6 43.7-65.5 81.8 65.4-98.2 Turbidimetric
mg/L 25.3 20.2-30.4 52.9 42.3-63.5 79.1 63.3-94.9 Nephelometric
mg/L 36.2 29.0-43.4 58.6 47-70.3 64.5 51.6-77.4 Vitros
Complement
C3
g/L 0.72 0.57-0.86 1.45 1.16-1.74 2.17 1.74-2.60
Turbidimetric
mg/dL 72.0 57.6-86.4 145 116-174 217 174-260
g/L 0.727 0.58-0.87 1.49 1.19-1.79 2.27 1.82-2.72
Nephelometric
mg/dL 72.7 58.2-87.2 149 119-179 227 182-272
g/L 0.714 0.57-0.85 1.40 1.12-1.68 2.15 1.72-2.58
Vitros
mg/dL 71.4 57.1-85.7 140 112-168 215 172-258
Complement
C4
g/L 0.175 0.14-0.21 0.35 0.28-0.42 0.53 0.42-0.63
Turbidimetric
mg/dL 17.5 14.0-21.0 35 28-42 53 42.4-63.6
g/L 0.196 0.15-0.23 0.399 0.31-0.47 0.60 0.48-0.72
Nephelometric
mg/dL 19.6 15.7-23.5 39.9 31.9-47.9 60.4 48.3-72.5
g/L 0.181 0.14-0.22 0.356 0.28-0.42 0.53 0.42-0.63
Vitros
mg/dL 18.1 14.5-21.7 35.6 28.5-42.7 53 42.4-63.6
Free Kappa
Light Chains
mg/L 17.9 14.3-21.5 29.9 23.9-35.9 34 25.5-42.5 Turbidimetric
mg/L 21.7 17.4-26.0 34.2 27.4-41.0 40.2 30.2-50.3 Nephelometric
Free Lambda
Light Chains
mg/L 16.9 13.5-20.3 29.4 23.5-35.3 40.3 30.2-50.4 Turbidimetric
mg/L 18.4 14.7-22.1 33.3 26.6-40 46.3 34.7-57.9 Nephelometric
IgA
g/L 1.22 0.91-1.53 2.42 1.82-3.03 3.65 2.74-4.56
Turbidimetric
mg/dL 122 91.5-153 242 182-302 365 274-456
g/L 1.29 0.96-1.61 2.64 1.98-3.30 4.04 3.03-5.05
Nephelometric
mg/dL 129 96.8-161 264 198-330 404 303-505
g/L 1.18 0.88-1.48 2.48 1.86-3.10 3.46 2.60-4.33
Vitros
mg/dL 118 88.5-148 248 186-310 346 260-432
IgE
KIU/L
=
IU/mL
89.3 71.4-107 175 140-210 262 210-314 Turbidimetric
KIU/L
=
IU/mL
100 80-120 198 158-238 310 248-372 Nephelometric
KIU/L
=
IU/mL
103 82.4-124 200 160-240 299 239-359 Chemiluminescence
KIU/L
=
IU/mL
100 80-120 211 169-253 299 239-359
Enzyme
Immunoassay
KIU/L
=
IU/mL
105 84-126 210 168-252 315 252-378 Fluorimetric
IgG
g/L 7.0 5.74-8.26 14 11.5-16.5 21 17.2-24.8
Turbidimetric
mg/dL 700 574-826 1400 1150-1650 2100 1720-2480
g/L 7.34 6.02-8.66 14.5 11.9-17.1 21.6 17.7-25.5
Nephelometric
mg/dL 734 602-866 1450 1190-1710 2160 1770-2550
g/L 7.14 5.85-8.43 14 11.5-16.5 19.6 16.1-23.1
Vitros
mg/dL 714 585-843 1400 1150-1650 1960 1610-2310
IgM
g/L 0.94 0.75-1.13 1.87 1.50-2.24 2.83 2.26-3.40
Turbidimetric
mg/dL 94 75.2-113 187 150-224 283 226-340
g/L 0.99 0.79-1.19 1.96 1.57-2.35 2.95 2.36-3.54
Nephelometric
mg/dL 99 79.2-119 196 157-235 295 236-354
g/L 0.917 0.73-1.10 1.97 1.58-2.36 2.73 2.18-3.28
Vitros
mg/dL 91.7 73.4-110 197 158-236 273 218-328
Kappa Light
Chain
g/L 1.83 1.46-2.20 3.71 2.97-4.45 5.55 4.16-6.94
Turbidimetric
mg/dL 183 146-220 371 297-445 555 416-694
g/L 1.87 1.50-2.24 3.57 2.86-4.28 5.40 4.05-6.75
Nephelometric
mg/dL 187 150-224 357 286-428 540 405-675
Lambda Light
Chain
g/L 0.924 0.73-1.11 1.87 1.50-2.24 2.89 2.17-3.61
Turbidimetric
mg/dL 92.4 73.9-111 187 150-224 289 217-361
g/L 0.962 0.77-1.15 1.88 1.50-2.26 2.87 2.15-3.59
Nephelometric
mg/dL 96.2 77-115 188 150-226 287 215-359
Results - Examples of typical ranges
Open vial stability
Temperature Time period
Recovery (%) for different
concentration levels for all
the analytes
+2ºC to +8ºC 30 days (from day 0) 90-110
Shelf life stability
Temperature Time period
Recovery (%) for different
concentration levels for all
the analytes
+2ºC to +8ºC 48 months 90-110
Stability
AFP Complement C3 Kappa Light Chain (free)
Albumin Complement C4 Lambda Light Chain
α-I-Antitrypsin CRP Lambda Light Chain (free)
α-I-Acid Glycoprotein Haptoglobin Prealbumin (Transthyretin)
α-2-Macroglobulin IgA Serum Ferritin
ASO IgE RF
Anti-thrombin III IgG RBP
β-2-Microglobulin IgM Total Protein
Ceruloplasmin Kappa Light Chain Transferrin
Analytes

FOCUS 2016 Poster: Specific Proteins

  • 1.
    W QUALITY CONTROL Human ready-to-usestable liquid multi-analyte control for specific proteins including antibody isotypes and complement components Spon-Smith C., Shanks A., Rodríguez M.L., Campbell J., FitzGerald S.P | Randox Laboratories Ltd - Diamond Road, Crumlin, County Antrim, N. Ireland, BT29 4QY, United Kingdom. Introduction The performance and interpretation of tests for the diagnosis and management of a variety of immune-mediated diseases requires the maintenance of high-quality output. Quality control material is required to monitor the accuracy and precision of the tests,this will lead to improved result quality. The use of liquid stable multi-analyte control material consolidates the test menu, reduces the risk of errors associated with reconstitution and decreases the operator training requirements. A human liquid ready-to-use,stable multi-analyte control containing antibody isotypes, complement components and other specific proteins is reported. Methodology •Three levels of human liquid control material containing 27 analytes were prepared. • Open vial stability was determined as the percentage recovery of each level of analyte opened and stored at +2°C to +8°C over a period of 30 days related to day 0 at +2°C to +8°C. • Shelf life was assessed as the percentage recovery of each level of analyte stored at +2°C to +8°C compared to the same material stored at -70°C over a 48 month period. Measurements were made on various automated systems. Conclusion Thehumanliquidmulti-analytecontrolmaterialforspecificproteinscontained27parameters at three levels covering clinically relevant ranges.This control material presented an open vial stability of 30 days and data supporting at least a 2 year shelf life.This control is of value as a convenient, ready-to-use material for clinical applications. Randox Laboratories Ltd, 55 Diamond Road, Crumlin, County Antrim, BT29 4QY, United Kingdom +44 (0) 28 9442 2413 +44 (0) 28 9445 2912 marketing@randox.com randoxqc.comQUALITY CONTROL Analyte Unit Level 1 Level 2 Level 3 Method Target Range Target Range Target Range CRP mg/L 27.5 22.0-33.0 54.6 43.7-65.5 81.8 65.4-98.2 Turbidimetric mg/L 25.3 20.2-30.4 52.9 42.3-63.5 79.1 63.3-94.9 Nephelometric mg/L 36.2 29.0-43.4 58.6 47-70.3 64.5 51.6-77.4 Vitros Complement C3 g/L 0.72 0.57-0.86 1.45 1.16-1.74 2.17 1.74-2.60 Turbidimetric mg/dL 72.0 57.6-86.4 145 116-174 217 174-260 g/L 0.727 0.58-0.87 1.49 1.19-1.79 2.27 1.82-2.72 Nephelometric mg/dL 72.7 58.2-87.2 149 119-179 227 182-272 g/L 0.714 0.57-0.85 1.40 1.12-1.68 2.15 1.72-2.58 Vitros mg/dL 71.4 57.1-85.7 140 112-168 215 172-258 Complement C4 g/L 0.175 0.14-0.21 0.35 0.28-0.42 0.53 0.42-0.63 Turbidimetric mg/dL 17.5 14.0-21.0 35 28-42 53 42.4-63.6 g/L 0.196 0.15-0.23 0.399 0.31-0.47 0.60 0.48-0.72 Nephelometric mg/dL 19.6 15.7-23.5 39.9 31.9-47.9 60.4 48.3-72.5 g/L 0.181 0.14-0.22 0.356 0.28-0.42 0.53 0.42-0.63 Vitros mg/dL 18.1 14.5-21.7 35.6 28.5-42.7 53 42.4-63.6 Free Kappa Light Chains mg/L 17.9 14.3-21.5 29.9 23.9-35.9 34 25.5-42.5 Turbidimetric mg/L 21.7 17.4-26.0 34.2 27.4-41.0 40.2 30.2-50.3 Nephelometric Free Lambda Light Chains mg/L 16.9 13.5-20.3 29.4 23.5-35.3 40.3 30.2-50.4 Turbidimetric mg/L 18.4 14.7-22.1 33.3 26.6-40 46.3 34.7-57.9 Nephelometric IgA g/L 1.22 0.91-1.53 2.42 1.82-3.03 3.65 2.74-4.56 Turbidimetric mg/dL 122 91.5-153 242 182-302 365 274-456 g/L 1.29 0.96-1.61 2.64 1.98-3.30 4.04 3.03-5.05 Nephelometric mg/dL 129 96.8-161 264 198-330 404 303-505 g/L 1.18 0.88-1.48 2.48 1.86-3.10 3.46 2.60-4.33 Vitros mg/dL 118 88.5-148 248 186-310 346 260-432 IgE KIU/L = IU/mL 89.3 71.4-107 175 140-210 262 210-314 Turbidimetric KIU/L = IU/mL 100 80-120 198 158-238 310 248-372 Nephelometric KIU/L = IU/mL 103 82.4-124 200 160-240 299 239-359 Chemiluminescence KIU/L = IU/mL 100 80-120 211 169-253 299 239-359 Enzyme Immunoassay KIU/L = IU/mL 105 84-126 210 168-252 315 252-378 Fluorimetric IgG g/L 7.0 5.74-8.26 14 11.5-16.5 21 17.2-24.8 Turbidimetric mg/dL 700 574-826 1400 1150-1650 2100 1720-2480 g/L 7.34 6.02-8.66 14.5 11.9-17.1 21.6 17.7-25.5 Nephelometric mg/dL 734 602-866 1450 1190-1710 2160 1770-2550 g/L 7.14 5.85-8.43 14 11.5-16.5 19.6 16.1-23.1 Vitros mg/dL 714 585-843 1400 1150-1650 1960 1610-2310 IgM g/L 0.94 0.75-1.13 1.87 1.50-2.24 2.83 2.26-3.40 Turbidimetric mg/dL 94 75.2-113 187 150-224 283 226-340 g/L 0.99 0.79-1.19 1.96 1.57-2.35 2.95 2.36-3.54 Nephelometric mg/dL 99 79.2-119 196 157-235 295 236-354 g/L 0.917 0.73-1.10 1.97 1.58-2.36 2.73 2.18-3.28 Vitros mg/dL 91.7 73.4-110 197 158-236 273 218-328 Kappa Light Chain g/L 1.83 1.46-2.20 3.71 2.97-4.45 5.55 4.16-6.94 Turbidimetric mg/dL 183 146-220 371 297-445 555 416-694 g/L 1.87 1.50-2.24 3.57 2.86-4.28 5.40 4.05-6.75 Nephelometric mg/dL 187 150-224 357 286-428 540 405-675 Lambda Light Chain g/L 0.924 0.73-1.11 1.87 1.50-2.24 2.89 2.17-3.61 Turbidimetric mg/dL 92.4 73.9-111 187 150-224 289 217-361 g/L 0.962 0.77-1.15 1.88 1.50-2.26 2.87 2.15-3.59 Nephelometric mg/dL 96.2 77-115 188 150-226 287 215-359 Results - Examples of typical ranges Open vial stability Temperature Time period Recovery (%) for different concentration levels for all the analytes +2ºC to +8ºC 30 days (from day 0) 90-110 Shelf life stability Temperature Time period Recovery (%) for different concentration levels for all the analytes +2ºC to +8ºC 48 months 90-110 Stability AFP Complement C3 Kappa Light Chain (free) Albumin Complement C4 Lambda Light Chain α-I-Antitrypsin CRP Lambda Light Chain (free) α-I-Acid Glycoprotein Haptoglobin Prealbumin (Transthyretin) α-2-Macroglobulin IgA Serum Ferritin ASO IgE RF Anti-thrombin III IgG RBP β-2-Microglobulin IgM Total Protein Ceruloplasmin Kappa Light Chain Transferrin Analytes